A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Clinical trial NCT07491497 · RECRUITING

Trial details

NCT number: NCT07491497
Sponsor: TRIANA Biomedicines, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ALK-positive NSCLC ALK-Positive Lung Cancer ALK-positive Non-small Cell Lung Cancer

Start date: 2026-03-11
Primary completion: 2029-05-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.